*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
Atlanta, GA | Posted: May 13, 2019
Summary Sentence:
Steve Stice: Using Living Cells to Change the Course of Disease
Full Summary:
Steve Stice: Using Living Cells to Change the Course of Disease
CMaT UGAFor the first time in U.S. history, the Census Bureau projects that by 2035 seniors will outnumber children. And as the population grays, a cloud of uncertainty over rising healthcare costs looms over the near horizon.
Healthcare spending is projected to accelerate over the next decade, and 60 percent of American adults are now living with at least one chronic condition. Chronic diseases like asthma, cancer, diabetes, and heart disease cost Georgia about $40 billion a year.
Steven Stice, GRA Eminent Scholar of Regenerative Medicine at the University of Georgia and a researcher with the Petit Institute for Bioengineering and Bioscience at Georgia Tech, believes one solution to combat the cost of chronic disease is to produce cell-based therapies in much larger quantities and more consistent quality.
And he isn’t alone.
